Cargando…
Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe
INTRODUCTION: Limited data exist on use of the microscopic-observation drug-susceptibility (MODS) assay among persons suspected of MDR-TB living in high HIV-prevalence settings. METHODS: We retrospectively reviewed available clinical and drug susceptibility data for drug-resistant TB suspects referr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569460/ https://www.ncbi.nlm.nih.gov/pubmed/23409072 http://dx.doi.org/10.1371/journal.pone.0055872 |
_version_ | 1782258911737282560 |
---|---|
author | Makamure, Beauty Mhaka, Jesca Makumbirofa, Salome Mutetwa, Reggie Mupfumi, Lucy Mason, Peter Metcalfe, John Z. |
author_facet | Makamure, Beauty Mhaka, Jesca Makumbirofa, Salome Mutetwa, Reggie Mupfumi, Lucy Mason, Peter Metcalfe, John Z. |
author_sort | Makamure, Beauty |
collection | PubMed |
description | INTRODUCTION: Limited data exist on use of the microscopic-observation drug-susceptibility (MODS) assay among persons suspected of MDR-TB living in high HIV-prevalence settings. METHODS: We retrospectively reviewed available clinical and drug susceptibility data for drug-resistant TB suspects referred for culture and drug-susceptibility testing between April 1, 2011 and March 1, 2012. The diagnostic accuracy of MODS was estimated against a reference standard including Löwenstein-Jensen (LJ) media and manual liquid (BACTEC MGIT) culture. The accuracy of MODS drug-susceptibility testing (DST) was assessed against a reference standard absolute concentration method. RESULTS: One hundred thirty-eight sputum samples were collected from 99 drug-resistant TB suspects; in addition, six previously cultured MDR isolates were included for assessment of DST accuracy. Among persons with known HIV infection status, 39/59 (66%) were HIV-infected. Eighty-six percent of patients had a history of prior TB treatment, and 80% of individuals were on antituberculous treatment at the time of sample collection. M. tuberculosis was identified by reference standard culture among 34/98 (35%) MDR-TB suspects. Overall MODS sensitivity for M. tuberculosis detection was 85% (95% CI, 69–95%) and specificity was 93% (95% CI, 84–98%); diagnostic accuracy did not significantly differ by HIV infection status. Median time to positivity was significantly shorter for MODS (7 days; IQR 7–15 days) than MGIT (12 days; IQR 6–16 days) or LJ (28 days; IQR 21–35 days; p<0.001). Of 33 specimens with concurrent DST results, sensitivity of the MODS assay for detection of resistance to isoniazid, rifampin, and MDR-TB was 88% (95% CI, 68–97%), 96% (95% CI, 79–100%), and 91% (95% CI, 72–99%), respectively; specificity was 89% (95% CI, 52–100%), 89% (95% CI, 52–100%), and 90% (95% CI, 56–100%), respectively. CONCLUSION: In a high HIV-prevalence setting, MODS diagnosed TB and drug-resistant TB with high sensitivity and shorter turnaround time compared with standard culture and DST methods. |
format | Online Article Text |
id | pubmed-3569460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35694602013-02-13 Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe Makamure, Beauty Mhaka, Jesca Makumbirofa, Salome Mutetwa, Reggie Mupfumi, Lucy Mason, Peter Metcalfe, John Z. PLoS One Research Article INTRODUCTION: Limited data exist on use of the microscopic-observation drug-susceptibility (MODS) assay among persons suspected of MDR-TB living in high HIV-prevalence settings. METHODS: We retrospectively reviewed available clinical and drug susceptibility data for drug-resistant TB suspects referred for culture and drug-susceptibility testing between April 1, 2011 and March 1, 2012. The diagnostic accuracy of MODS was estimated against a reference standard including Löwenstein-Jensen (LJ) media and manual liquid (BACTEC MGIT) culture. The accuracy of MODS drug-susceptibility testing (DST) was assessed against a reference standard absolute concentration method. RESULTS: One hundred thirty-eight sputum samples were collected from 99 drug-resistant TB suspects; in addition, six previously cultured MDR isolates were included for assessment of DST accuracy. Among persons with known HIV infection status, 39/59 (66%) were HIV-infected. Eighty-six percent of patients had a history of prior TB treatment, and 80% of individuals were on antituberculous treatment at the time of sample collection. M. tuberculosis was identified by reference standard culture among 34/98 (35%) MDR-TB suspects. Overall MODS sensitivity for M. tuberculosis detection was 85% (95% CI, 69–95%) and specificity was 93% (95% CI, 84–98%); diagnostic accuracy did not significantly differ by HIV infection status. Median time to positivity was significantly shorter for MODS (7 days; IQR 7–15 days) than MGIT (12 days; IQR 6–16 days) or LJ (28 days; IQR 21–35 days; p<0.001). Of 33 specimens with concurrent DST results, sensitivity of the MODS assay for detection of resistance to isoniazid, rifampin, and MDR-TB was 88% (95% CI, 68–97%), 96% (95% CI, 79–100%), and 91% (95% CI, 72–99%), respectively; specificity was 89% (95% CI, 52–100%), 89% (95% CI, 52–100%), and 90% (95% CI, 56–100%), respectively. CONCLUSION: In a high HIV-prevalence setting, MODS diagnosed TB and drug-resistant TB with high sensitivity and shorter turnaround time compared with standard culture and DST methods. Public Library of Science 2013-02-11 /pmc/articles/PMC3569460/ /pubmed/23409072 http://dx.doi.org/10.1371/journal.pone.0055872 Text en © 2013 Makamure et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Makamure, Beauty Mhaka, Jesca Makumbirofa, Salome Mutetwa, Reggie Mupfumi, Lucy Mason, Peter Metcalfe, John Z. Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe |
title | Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe |
title_full | Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe |
title_fullStr | Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe |
title_full_unstemmed | Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe |
title_short | Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe |
title_sort | microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in harare, zimbabwe |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569460/ https://www.ncbi.nlm.nih.gov/pubmed/23409072 http://dx.doi.org/10.1371/journal.pone.0055872 |
work_keys_str_mv | AT makamurebeauty microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe AT mhakajesca microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe AT makumbirofasalome microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe AT mutetwareggie microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe AT mupfumilucy microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe AT masonpeter microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe AT metcalfejohnz microscopicobservationdrugsusceptibilityassayforthediagnosisofdrugresistanttuberculosisinhararezimbabwe |